| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
|
Circulation
|
2011
|
6.36
|
|
2
|
Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
|
Circulation
|
2010
|
2.62
|
|
3
|
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
|
Circulation
|
2010
|
2.49
|
|
4
|
Cardiopulmonary resuscitation quality: [corrected] improving cardiac resuscitation outcomes both inside and outside the hospital: a consensus statement from the American Heart Association.
|
Circulation
|
2013
|
2.49
|
|
5
|
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
|
J Am Coll Cardiol
|
2010
|
2.41
|
|
6
|
Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials.
|
Am J Med
|
2005
|
2.08
|
|
7
|
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry.
|
J Am Coll Cardiol
|
2004
|
1.77
|
|
8
|
Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion.
|
J Am Coll Cardiol
|
2008
|
1.68
|
|
9
|
International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2011
|
1.65
|
|
10
|
Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?
|
Am Heart J
|
2005
|
1.56
|
|
11
|
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
|
JAMA
|
2013
|
1.54
|
|
12
|
Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns.
|
Acad Emerg Med
|
2005
|
1.49
|
|
13
|
Do bisphosphonates slow the progression of aortic stenosis?
|
J Am Coll Cardiol
|
2012
|
1.48
|
|
14
|
Magnitude and consequences of missing the acute infarct-related circumflex artery.
|
Am Heart J
|
2009
|
1.42
|
|
15
|
Status of women in cardiovascular clinical trials.
|
Arterioscler Thromb Vasc Biol
|
2009
|
1.41
|
|
16
|
Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support.
|
Heart
|
2010
|
1.40
|
|
17
|
Options for managing severe aortic stenosis: a case-based review.
|
Cleve Clin J Med
|
2013
|
1.40
|
|
18
|
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
|
Arch Intern Med
|
2012
|
1.21
|
|
19
|
Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock.
|
Arch Intern Med
|
2005
|
1.12
|
|
20
|
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
|
Am Heart J
|
2012
|
1.06
|
|
21
|
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association.
|
Circulation
|
2013
|
1.04
|
|
22
|
The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative.
|
Am Heart J
|
2009
|
1.04
|
|
23
|
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
|
Eur Heart J
|
2009
|
1.04
|
|
24
|
Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
|
Chest
|
2008
|
1.03
|
|
25
|
Part 9: Acute Coronary Syndromes: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
|
Circulation
|
2015
|
1.00
|
|
26
|
Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE).
|
Am Heart J
|
2006
|
0.97
|
|
27
|
Spontaneous coronary artery dissection in Ehlers-Danlos syndrome.
|
Ann Thorac Surg
|
2011
|
0.95
|
|
28
|
The challenges in the management of right ventricular infarction.
|
Eur Heart J Acute Cardiovasc Care
|
2013
|
0.91
|
|
29
|
Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients.
|
J Nucl Cardiol
|
2010
|
0.89
|
|
30
|
Inferior vena cava thrombus associated with intravascular cooling catheter.
|
Resuscitation
|
2010
|
0.88
|
|
31
|
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb.
|
J Thromb Thrombolysis
|
2002
|
0.87
|
|
32
|
Utility of a novel watch-based pulse detection system to detect pulselessness in human subjects.
|
Heart Rhythm
|
2011
|
0.85
|
|
33
|
Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease.
|
Ann Thorac Surg
|
2008
|
0.85
|
|
34
|
Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis.
|
J Thorac Cardiovasc Surg
|
2011
|
0.85
|
|
35
|
Predictors and incremental prognostic value of left ventricular mechanical dyssynchrony response during stress-gated positron emission tomography in patients with ischemic cardiomyopathy.
|
J Nucl Cardiol
|
2012
|
0.84
|
|
36
|
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
|
Am Heart J
|
2006
|
0.83
|
|
37
|
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
|
Am J Cardiol
|
2012
|
0.82
|
|
38
|
Transfer of patients with suspected acute aortic syndrome.
|
Am J Cardiol
|
2013
|
0.81
|
|
39
|
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association.
|
Circulation
|
2015
|
0.81
|
|
40
|
Ranolazine: clinical applications and therapeutic basis.
|
Am J Cardiovasc Drugs
|
2013
|
0.80
|
|
41
|
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.
|
Am Heart J
|
2009
|
0.80
|
|
42
|
Hypothermia after cardiac arrest: beneficial, but slow to be adopted.
|
Cleve Clin J Med
|
2011
|
0.79
|
|
43
|
Safety of ultrasound contrast agents in stress echocardiography.
|
Am J Cardiol
|
2008
|
0.79
|
|
44
|
Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial).
|
Am J Cardiol
|
2011
|
0.78
|
|
45
|
Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock.
|
J Invasive Cardiol
|
2013
|
0.78
|
|
46
|
State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shock.
|
Heart
|
2013
|
0.78
|
|
47
|
Contemporary drug treatment of infective endocarditis.
|
Am J Cardiovasc Drugs
|
2013
|
0.78
|
|
48
|
Relationship between baseline resting diastolic function and exercise capacity in patients with hypertrophic cardiomyopathy undergoing treadmill stress echocardiography: a cohort study.
|
BMJ Open
|
2012
|
0.77
|
|
49
|
Cardiogenic shock: have we really found the magic potion?
|
Eur Heart J
|
2003
|
0.77
|
|
50
|
Clinical predictors and characteristics of patients with chronic liver disease and intrapulmonary shunts.
|
Clin Cardiol
|
2005
|
0.77
|
|
51
|
Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study.
|
Ann Intern Med
|
2014
|
0.77
|
|
52
|
Measuring and treating serum lipids in patients in a chest pain observation unit.
|
Am J Cardiol
|
2007
|
0.77
|
|
53
|
Meta-analysis of the cardiovascular outcomes with dipeptidyl peptidase 4 inhibitors: validation of the current FDA mandate.
|
Am J Cardiovasc Drugs
|
2014
|
0.77
|
|
54
|
Incremental prognostic value of diastolic dysfunction in low risk patients undergoing echocardiography: beyond Framingham score.
|
Int J Cardiovasc Imaging
|
2013
|
0.77
|
|
55
|
Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study).
|
Am J Cardiol
|
2007
|
0.76
|
|
56
|
Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study.
|
BMC Cardiovasc Disord
|
2013
|
0.75
|
|
57
|
An algorithmic approach to ST-elevation myocardial infarction triage: effective but not foolproof.
|
Am Heart J
|
2012
|
0.75
|
|
58
|
Blunt traumatic aortic transection.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
59
|
Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest.
|
Catheter Cardiovasc Interv
|
2011
|
0.75
|
|
60
|
Trends in the Use of Mechanical Circulatory Support Devices in Patients Presenting With ST-Segment Elevation Myocardial Infarction.
|
JACC Cardiovasc Interv
|
2015
|
0.75
|
|
61
|
Dynamic outflow tract obstruction in congenitally corrected transposition of the great arteries.
|
Int J Cardiovasc Imaging
|
2010
|
0.75
|
|
62
|
Dual antiplatelet therapy in coronary artery disease: a case-based approach.
|
Cleve Clin J Med
|
2009
|
0.75
|
|
63
|
Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trial.
|
J Cardiovasc Nurs
|
2007
|
0.75
|
|
64
|
Images in cardiovascular medicine. Acute myocardial infarction in uncorrected tetralogy of fallot.
|
Circulation
|
2002
|
0.75
|
|
65
|
Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndrome.
|
Am J Cardiol
|
2006
|
0.75
|
|
66
|
Giant osborn waves seen in a patient with hypothermia associated with status epilepticus-induced diffuse cerebral injury.
|
Ther Hypothermia Temp Manag
|
2011
|
0.75
|
|
67
|
Establishing a new target range for unfractionated heparin for acute coronary syndromes.
|
J Thromb Thrombolysis
|
2004
|
0.75
|
|
68
|
Troponin Elevation After Colorectal Surgery: Significance and Management.
|
Ann Surg
|
2016
|
0.75
|
|
69
|
Images in cardiovascular medicine. Left anterior descending coronary artery occlusion secondary to blunt chest trauma.
|
Circulation
|
2009
|
0.75
|
|
70
|
Accessory mitral valve associated with mitral cleft, bicuspid aortic valve, and aortic coarctation.
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
71
|
An unusual etiology for chest discomfort and the importance of systematic scintigraphic review.
|
Clin Cardiol
|
2009
|
0.75
|
|
72
|
Hemopericardium, shock, and a linear density in the ascending aorta: is it a dissection?
|
J Am Coll Cardiol
|
2012
|
0.75
|
|
73
|
The Time-Varying Risk of Cardiovascular and Noncardiovascular Readmissions Early After Acute Myocardial Infarction.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
74
|
Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes.
|
Am Heart J
|
2004
|
0.75
|
|
75
|
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
|
Circulation
|
2017
|
0.75
|